APPROACHES FOR A MODEL OF POPULATION UROLOGICAL SCREENING BASED ON TELEMEDICINE TECHNOLOGIES

Background. The prostate cancer wins a first place among men oncological diseases by rates of an incidence and mortality. The late detection is a main reason of high mortality (approximately 52,0% patients starts treatment after more than 1 year of symptoms existence). A screening allows improve detection dramatically, but current methods of screening almost impossible to use widely. System of oncological urology needs new effective approaches for population screening. Aim. To develop empirical approaches for a model of population urological screening with a telemedicine as a key element. Material and methods. The research are backgrounded on systemic approach. Methods of analysis, synthesis and information modeling were used. Methodological documents recognized by WHO used for model evaluation. Results and discussion. National program of an urological screening should be backgrounded on methods of selective staged examinations of target population group, telemedicine technologies must be a key integrative element. The formal information model of prostate cancer telemedicine screening was developed. The key element of the model is an information system which consist from: - web-questionnaires and online risk assessment forms, - Electronic health records module, - Laboratory module, - PACS. The model was developed according to criterion for screening programs recognized by WHO. Conclusion. Approaches for an urological screening organization had been developed empirically. All issues joints the formal information model of prostate cancer telemedicine screening. The model are valid according to WHO methodological documents. Further researches will be focused on model introduction and evaluation in the field.

1. Butrina VI. Organiza on of diagnos c and treatment medical care to pa ents with prostate cancer at the diagnos c and treatment urology department. Sotsial’nye aspekty zdorov’ya naseleniya. 2014; 1(35):3. (In Russ.)

2. Startsev VY, Akinshevich IY. Dynamics of sta s cal indicators of medical care for inhabitants of the Republic of Crimea in cases of the genitourinary tract neoplasms. Herald Urology. 2015;(4):3-15. (In Russ.)

3. Gu lla A, Bortolami A, Evangelista L. Prostate cancer as a chronic disease: cost-eff ec veness and proper followup. Q J Nucl Med Mol Imaging. 2015;59(4):439-45.

4. Apolikhin OI, Ka bov MI, Sivkov AV, Chernishev IV, Roschin DA, Shaderkin IA, Moskaleva NG, Efremov GD, Kuraeva VM. Problems of prostate cancer screening induced by comprehensive medical examina on in the Russian Federa on. Sotsial’nye aspekty zdorov’ya naseleniya. 2013;(6):1. (In Russ.)

5. Apolikhin OI, Sivkov AV, Ka bov MI, Chernyshev IV, Zhernov AA, Koryakin AV. Compara ve Analysis of Radical Prostatectomy and Brachytherapy Clinical and Economical Results. Eksperimental’naya i klinicheskaya urologiya. 2011;(1):11-16. (In Russ.)

6. Apolikhin OI, Sivkov AV, Ka bov MI, Roschin DA, Shaderkin IA, Koryakin AV. Prostate cancer screening: evalua on of clinical and economic eff ec veness. Eksperimental’naya i klinicheskaya urologiya. 2015;(2):20-24. (In Russ.)

7. Kaprin AV, Starinskiy VV, Petrova GV eds. Zlokachestvennye novoobrazovaniya v Rossii v 2014 godu (zabolevaemost’ i smertnost’). Moscow: Na onal Medical Research Radiology Center;2016. (In Russ.)

8. Kaprin AV, Apolikhin OI, Sivkov AV, Moskaleva NG, Solnceva TV, Komarova VA. Analysis of uronephrological morbidity and mortality in Russian Federa on for 20032013. Eksperimental’naya i klinicheskaya urologiya. 2015;(2):4-12. (In Russ.)

9. Krotov KYu. Medical and organiza onal support of improving care for pa ents with prostate cancer. Vrachaspirant. 2015;6(73):125-133. (In Russ.)

10. Cochrane AL, Holland WW. Valida on of screening procedures. British Medical Bulletin. 1971;27(1):3-8.

11. Holland WW, Stewart S, Masseria C. Osnovy poli ki. Skrining v Evrope. WHO;2008. (In Russ.)

12. Engalychev FSh, Mironov MA, Galkina NG, Galkin AV, Durdenevsky NB, Syskova MA. Results of a goal-oriented prostate cancer screening program in the Penza Region. Onkourologiya. 2012;(1):62-65. (In Russ.)

13. Orlov AE, Egorova AG, Starinskiy VV. Analiz onkoepidemiologicheskikh tendentsii v regionakh Rossiiskoi Federatsii – osnova uspeshnoi realizatsii territorial’nykh programm profi lak ki raka. Samara: Izdatelstvo As Gard; 2014. (In Russ.)

14. Chernov NA, Vereshagin II, Galkin VV, Ismailov AM, Sivkov AV. Results of a goal-oriented prostate cancer screening program in the Penza Region. Eksperimental’naya i klinicheskaya urologiya. 2010;(2):11−14. (In Russ.)

15. Vladzymyrskyy AV. Telemeditsina: Cura o Sine Tempora et Distan a.Moscow; 2016. (In Russ.)

16. Brawley OW, Thompson IM Jr, Grönberg H. Evolving Recommenda ons on Prostate Cancer Screening. Am Soc Clin Oncol Educ Book. 2016;35:e80-7. doi: 10.14694/ EDBK_157413

17. Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M.A posi ve family history as a risk factor for prostate cancer in a popula on-based study with organised prostate-specifi c an gen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int. 2016;117(4):576-83. doi: 10.1111/bju.13310